MedinCell Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Christophe Douat
Chief executive officer
€521.8k
Total compensation
| CEO salary percentage | 51.2% |
| CEO tenure | 9.8yrs |
| CEO ownership | n/a |
| Management average tenure | 3.6yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
Revenues Tell The Story For MedinCell S.A. (EPA:MEDCL) As Its Stock Soars 30%
Apr 26
Market Participants Recognise MedinCell S.A.'s (EPA:MEDCL) Revenues Pushing Shares 26% Higher
Jan 09The MedinCell (EPA:MEDCL) Share Price Is Up 75% And Shareholders Are Holding On
Mar 02Is MedinCell S.A. (EPA:MEDCL) Popular Amongst Insiders?
Jan 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -€26m |
| Jun 30 2023 | n/a | n/a | -€29m |
| Mar 31 2023 | €522k | €267k | -€32m |
| Dec 31 2022 | n/a | n/a | -€29m |
| Sep 30 2022 | n/a | n/a | -€27m |
| Jun 30 2022 | n/a | n/a | -€26m |
| Mar 31 2022 | €329k | €258k | -€25m |
| Dec 31 2021 | n/a | n/a | -€22m |
| Sep 30 2021 | n/a | n/a | -€20m |
| Jun 30 2021 | n/a | n/a | -€19m |
| Mar 31 2021 | €336k | €235k | -€19m |
| Dec 31 2020 | n/a | n/a | -€22m |
| Sep 30 2020 | n/a | n/a | -€26m |
| Jun 30 2020 | n/a | n/a | -€25m |
| Mar 31 2020 | €301k | €232k | -€24m |
| Dec 31 2019 | n/a | n/a | -€21m |
| Sep 30 2019 | n/a | n/a | -€19m |
| Jun 30 2019 | n/a | n/a | -€19m |
| Mar 31 2019 | €244k | €192k | -€20m |
| Dec 31 2018 | n/a | n/a | -€17m |
| Sep 30 2018 | n/a | n/a | -€15m |
| Jun 30 2018 | n/a | n/a | -€12m |
| Mar 31 2018 | €175k | €149k | -€10m |
Compensation vs Market: Christophe's total compensation ($USD558.23K) is about average for companies of similar size in the French market ($USD603.24K).
Compensation vs Earnings: Christophe's compensation has increased whilst the company is unprofitable.
CEO
Christophe Douat (57 yo)
9.8yrs
Tenure
€521,830
Compensation
Mr. Christophe Douat serves as Chairman of the Management Board and Chief Executive officer at MedinCell S.A and served as General Manager. Mr. Douat serves as an Investment Director of Matignon Investisse...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of Executive Board | 9.8yrs | €521.83k | no data | |
| Chief People Officer & Member of the Management Board | 4yrs | €270.86k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Head of Legal | 3.3yrs | no data | no data | |
| Head of Communications | no data | no data | no data | |
| Head of Research & Development | no data | no data | no data | |
| Chief Business Officer | 2.3yrs | no data | no data | |
| Head of Alliance & Project Management | 4.8yrs | no data | no data | |
| Head of Global Health Development | 7.4yrs | no data | no data | |
| Chief Medical Officer | 2yrs | no data | no data | |
| Head of Pharmaceutical Operations | no data | no data | no data | |
| Senior Communications Officer | no data | no data | no data |
3.6yrs
Average Tenure
Experienced Management: MEDCL's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Supervisory Board Member | 1.8yrs | €55.18k | no data | |
| Independent Member of the Supervisory Board | 6.8yrs | €25.00k | no data | |
| Independent Chairman of Supervisory Board | 13.4yrs | €60.60k | no data | |
| Independent Member of Supervisory Board | 7.9yrs | €46.30k | no data | |
| Censor | no data | no data | no data | |
| Supervisory Board Member | 3.3yrs | €47.88k | no data |
6.8yrs
Average Tenure
Experienced Board: MEDCL's board of directors are considered experienced (6.8 years average tenure).